Since 2015, we have developed a comprehensive portfolio of diabetes treatment products, including glargine, lispro, and aspart insulin injections, as well as insulin delivery devices and needles. Today, our established global business network spans over 19 countries and regions across the Americas, Europe, Eurasia, Asia-Pacific, and Africa.
Zeptide Pharma is the industry-preferred boutique contract manufacturer dedicated to the production of insulin and biosimilar drugs
Partner with Us: Sterile Contract Chemistry Industry
Manufacturing Medical Device Medicines & Investigational New Drugs
